Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea

Tae Geun Gweon; Yoo Jin Lee; Kyeong Ok Kim; Sung Kyun Yim; Jae Seung Soh; Seung Young Kim; Jae Jun Park; Seung Yong Shin; Tae Hee Lee; Chang Hwan Choi; Young Seok Cho; Dongeun Yong; Jin Won Chung; Kwang Jae Lee; Oh Young Lee; Myung Gyu Choi; Miyoung Choi

doi:10.5056/jnm21221

Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea

Tae Geun Gweon, Yoo Jin Lee, Kyeong Ok Kim, Sung Kyun Yim, Jae Seung Soh, Seung Young Kim, Jae Jun Park, Seung Yong Shin, Tae Hee Lee, Chang Hwan Choi, Young Seok Cho, Dongeun Yong, Jin Won Chung, Kwang Jae Lee, Oh Young Lee, Myung Gyu Choi, Miyoung Choi

Department of Laboratory Medicine

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

Fecal microbiota transplantation (FMT) is a highly efficacious and safe modality for the treatment of recurrent or refractory Clostridioides difficile infection (CDI), with overall success rates of 90%. Thus, FMT has been widely used for 10 years. The incidence and clinical characteristics of CDI, the main indication for FMT, differ between countries. To date, several guidelines have been published. However, most of them were published in Western countries and therefore cannot represent the Korean national healthcare systems. One of the barriers to performing FMT is a lack of national guidelines. Accordingly, multidisciplinary experts in this field have developed practical guidelines for FMT. The purpose of these guidelines is to aid physicians performing FMT, which can be adapted to treat CDI and other conditions.

Original language	English
Pages (from-to)	28-42
Number of pages	15
Journal	Journal of Neurogastroenterology and Motility
Volume	28
Issue number	1
DOIs	https://doi.org/10.5056/jnm21221
Publication status	Published - 2022 Jan

Bibliographical note

Funding Information:
Financial support: This research was supported by a grant of

Publisher Copyright:
© 2022 The Korean Society of Neurogastroenterology and Motility

All Science Journal Classification (ASJC) codes

Clinical Neurology
Gastroenterology

Access to Document

10.5056/jnm21221

Cite this

Gweon, T. G., Lee, Y. J., Kim, K. O., Yim, S. K., Soh, J. S., Kim, S. Y., Park, J. J., Shin, S. Y., Lee, T. H., Choi, C. H., Cho, Y. S., Yong, D., Chung, J. W., Lee, K. J., Lee, O. Y., Choi, M. G., & Choi, M. (2022). Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea. Journal of Neurogastroenterology and Motility, 28(1), 28-42. https://doi.org/10.5056/jnm21221

@article{3561f998cfb04887ab549859d6511bff,

title = "Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea",

abstract = "Fecal microbiota transplantation (FMT) is a highly efficacious and safe modality for the treatment of recurrent or refractory Clostridioides difficile infection (CDI), with overall success rates of 90%. Thus, FMT has been widely used for 10 years. The incidence and clinical characteristics of CDI, the main indication for FMT, differ between countries. To date, several guidelines have been published. However, most of them were published in Western countries and therefore cannot represent the Korean national healthcare systems. One of the barriers to performing FMT is a lack of national guidelines. Accordingly, multidisciplinary experts in this field have developed practical guidelines for FMT. The purpose of these guidelines is to aid physicians performing FMT, which can be adapted to treat CDI and other conditions.",

author = "Gweon, {Tae Geun} and Lee, {Yoo Jin} and Kim, {Kyeong Ok} and Yim, {Sung Kyun} and Soh, {Jae Seung} and Kim, {Seung Young} and Park, {Jae Jun} and Shin, {Seung Yong} and Lee, {Tae Hee} and Choi, {Chang Hwan} and Cho, {Young Seok} and Dongeun Yong and Chung, {Jin Won} and Lee, {Kwang Jae} and Lee, {Oh Young} and Choi, {Myung Gyu} and Miyoung Choi",

note = "Funding Information: Financial support: This research was supported by a grant of Publisher Copyright: {\textcopyright} 2022 The Korean Society of Neurogastroenterology and Motility",

year = "2022",

month = jan,

doi = "10.5056/jnm21221",

language = "English",

volume = "28",

pages = "28--42",

journal = "Journal of Neurogastroenterology and Motility",

issn = "2093-0879",

publisher = "Korean Society of Neurogastroenterology and Motility",

number = "1",

}

TY - JOUR

T1 - Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea

AU - Gweon, Tae Geun

AU - Lee, Yoo Jin

AU - Kim, Kyeong Ok

AU - Yim, Sung Kyun

AU - Soh, Jae Seung

AU - Kim, Seung Young

AU - Park, Jae Jun

AU - Shin, Seung Yong

AU - Lee, Tae Hee

AU - Choi, Chang Hwan

AU - Cho, Young Seok

AU - Yong, Dongeun

AU - Chung, Jin Won

AU - Lee, Kwang Jae

AU - Lee, Oh Young

AU - Choi, Myung Gyu

AU - Choi, Miyoung

PY - 2022/1

Y1 - 2022/1

N2 - Fecal microbiota transplantation (FMT) is a highly efficacious and safe modality for the treatment of recurrent or refractory Clostridioides difficile infection (CDI), with overall success rates of 90%. Thus, FMT has been widely used for 10 years. The incidence and clinical characteristics of CDI, the main indication for FMT, differ between countries. To date, several guidelines have been published. However, most of them were published in Western countries and therefore cannot represent the Korean national healthcare systems. One of the barriers to performing FMT is a lack of national guidelines. Accordingly, multidisciplinary experts in this field have developed practical guidelines for FMT. The purpose of these guidelines is to aid physicians performing FMT, which can be adapted to treat CDI and other conditions.

AB - Fecal microbiota transplantation (FMT) is a highly efficacious and safe modality for the treatment of recurrent or refractory Clostridioides difficile infection (CDI), with overall success rates of 90%. Thus, FMT has been widely used for 10 years. The incidence and clinical characteristics of CDI, the main indication for FMT, differ between countries. To date, several guidelines have been published. However, most of them were published in Western countries and therefore cannot represent the Korean national healthcare systems. One of the barriers to performing FMT is a lack of national guidelines. Accordingly, multidisciplinary experts in this field have developed practical guidelines for FMT. The purpose of these guidelines is to aid physicians performing FMT, which can be adapted to treat CDI and other conditions.

UR - http://www.scopus.com/inward/record.url?scp=85123001237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123001237&partnerID=8YFLogxK

U2 - 10.5056/jnm21221

DO - 10.5056/jnm21221

M3 - Article

AN - SCOPUS:85123001237

SN - 2093-0879

VL - 28

SP - 28

EP - 42

JO - Journal of Neurogastroenterology and Motility

JF - Journal of Neurogastroenterology and Motility

IS - 1

ER -

Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this